IP
CORT icon

Intellectus Partners’s Corcept Therapeutics CORT Stock Holding History

Intellectus Partners’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.43M Sell
28,000
-3,000
-10% -$181K 0.42% 57
2026
Q1 		$1.25M Hold
31,000
– – 0.26% 109
2025
Q4 		$1.08M Sell
31,000
-11,051
-26% -$868K 0.21% 122
2025
Q3 		$3.49M Sell
42,051
-200
-0.5% -$14.5K 0.68% 30
2025
Q2 		$3.1M Buy
42,251
+200
+0.5% +$14.5K 0.67% 32
2025
Q1 		$4.8M Sell
42,051
-7,808
-16% -$475K 1.18% 15
2024
Q4 		$2.51M Sell
49,859
-5,000
-9% -$262K 0.56% 42
2024
Q3 		$2.54M Buy
+54,859
New +$1.95M 0.65% 37
2020
Q1 		– Sell
-11,300
Closed -$137K – 198
2019
Q4 		$137K Sell
11,300
-2,300
-17% -$32K 0.06% 195
2019
Q3 		$192K Buy
13,600
+1,554
+13% +$19.1K 0.08% 185
2019
Q2 		$134K Buy
12,046
+1,000
+9% +$11.1K 0.06% 188
2019
Q1 		$130K Sell
11,046
-7,528
-41% -$93.5K 0.06% 209
2018
Q4 		$248K Sell
18,574
-119,800
-87% -$1.58M 0.17% 111
2018
Q3 		$1.94M Buy
138,374
+1,500
+1% +$21K 0.68% 28
2018
Q2 		$2.15M Buy
136,874
+178
+0.1% +$3.1K 0.79% 28
2018
Q1 		$2.25M Sell
136,696
-2,250
-2% -$41.7K 0.77% 25
2017
Q4 		$2.51M Sell
138,946
-10,000
-7% -$181K 0.94% 21
2017
Q3 		$2.88M Sell
148,946
-1,050
-0.7% -$15.7K 1.19% 12
2017
Q2 		$1.77M Sell
149,996
-500
-0.3% -$5.43K 0.8% 27
2017
Q1 		$1.65M Sell
150,496
-19,926
-12% -$175K 0.84% 24
2016
Q4 		$1.1M Buy
+170,422
New +$1.34M 0.57% 42

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Intellectus Partners's CORT Position: Q2 2026 in Review

Intellectus Partners reduced its Corcept Therapeutics (CORT) stake by 9.7% in Q2 2026, selling an estimated $181K and leaving 28,000 shares worth $2.43M. The position accounts for 0.42% of the portfolio, ranked #57.

Intellectus Partners first reported a position in CORT in Q4 2016 and has held it in 21 quarters since. The position peaked at $4.8M in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Intellectus Partners held 28,000 shares of Corcept Therapeutics worth $2.43M as of Q2 2026.
  • Intellectus Partners sold 3,000 Corcept Therapeutics shares in Q2 2026, an estimated $181K.
  • Corcept Therapeutics made up 0.42% of Intellectus Partners's portfolio in Q2 2026, its #57 holding.
  • Intellectus Partners first reported a position in Corcept Therapeutics in Q4 2016 and has held it in 21 quarters since.
  • Intellectus Partners's Corcept Therapeutics position peaked at $4.8M in Q1 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Intellectus Partners's 13F filing for Q2 2026, filed 12 Aug 2026.